<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00332943</url>
  </required_header>
  <id_info>
    <org_study_id>KA-20060039 MA</org_study_id>
    <secondary_id>KA-20060039.</secondary_id>
    <nct_id>NCT00332943</nct_id>
  </id_info>
  <brief_title>MR Colonography With Fecal Tagging. Barium vs. BariumFerumoxsil</brief_title>
  <official_title>MR Colonography With Fecal Tagging. Barium vs. BariumFerumoxsil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herlev Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Gentofte, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Herlev Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Barium or BariumFerumoxsil is better for
      fecal tagging in MR colonography. Patients referred to colonoscopy are offered MR
      colonography before colonoscopy. Two days before colonography, patients ingest either a
      contrast agent A (200 ml Barium sulphate solution 1g/ml)) four times a day or a 200 ml
      contrast agent B (Barium sulfate(25%) and Ferumoxil(75%)) four times a day, which will render
      fecal masses &quot;invisible&quot; on the following MR colonography. The patients are randomised to
      either contrast agent A or B. The examinations are evaluated by two independent blinded
      readers, who will rate the tagging quality of the contrast agents. The quality of tagging
      will be rated by a Visual Analog Scale (VAS) and Relative contrast (ReCon = Iwall - Ilumen/
      Iwall + Ilumen).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">May 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of fecal tagging agent</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Sensitivity of VAS score vs. ReCon score</measure>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Polyps</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MR colonography with fecal tagging</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suspicion of colorectal polyps or cancer

          -  Referred for colonoscopy

        Exclusion Criteria:

          -  Suspicion of IBD

          -  Pacemaker

          -  Metal in the body

          -  Claustrophobia

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael P Achiam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Radiology Copenhagen University Hospital Herlev</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Radiology Copenhagen University Hospital Herlev</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2006</study_first_submitted>
  <study_first_submitted_qc>June 1, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2006</study_first_posted>
  <last_update_submitted>September 19, 2007</last_update_submitted>
  <last_update_submitted_qc>September 19, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2007</last_update_posted>
  <keyword>colorectal polyps</keyword>
  <keyword>colorectal cancer</keyword>
  <keyword>Virtual colonoscopy</keyword>
  <keyword>Fecal tagging</keyword>
  <keyword>MR colonography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

